These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer. Kochhar R; Renehan AG; Mullan D; Chakrabarty B; Saunders MP; Carrington BM Eur Radiol; 2017 Feb; 27(2):607-617. PubMed ID: 27090113 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China. Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection. Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048 [TBL] [Abstract][Full Text] [Related]
14. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis. Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768 [TBL] [Abstract][Full Text] [Related]
15. Genetic Analysis in Anal and Cervical Cancer: Exploratory Findings About Radioresistance in the ProfiLER Database. Rowinski E; Magne N; Bouleftour W; Moreno-Acosta P; DE LA Fourchadiere C; Ray-Coquard I; Wang Q; Blay JY; Tredan O Cancer Genomics Proteomics; 2021; 18(4):515-520. PubMed ID: 34183384 [TBL] [Abstract][Full Text] [Related]
16. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy. Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766 [TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis. Dasgupta T; Rothenstein D; Chou JF; Zhang Z; Wright JL; Saltz LB; Temple LK; Paty PB; Weiser MR; Guillem JG; Nash GM; Goodman KA Radiother Oncol; 2013 May; 107(2):189-94. PubMed ID: 23692961 [TBL] [Abstract][Full Text] [Related]
18. Molecular and genomic characterisation of a panel of human anal cancer cell lines. Guerra GR; Kong JC; Millen RM; Read M; Liu DS; Roth S; Sampurno S; Sia J; Bernardi MP; Chittleborough TJ; Behrenbruch CC; Teh J; Xu H; Haynes NM; Yu J; Lupat R; Hawkes D; Di Costanzo N; Tothill RW; Mitchell C; Ngan SY; Heriot AG; Ramsay RG; Phillips WA Cell Death Dis; 2021 Oct; 12(11):959. PubMed ID: 34663790 [TBL] [Abstract][Full Text] [Related]
19. Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinoma. Rogers JE; Jácome AAA; Ohinata A; Wolff R; Morris VK; Johnson B; Mehdizadeh A; Rothschild ND; Ahmed SU; Guerra JL; Eng C Expert Rev Anticancer Ther; 2020 Oct; 20(10):901-908. PubMed ID: 32799569 [TBL] [Abstract][Full Text] [Related]
20. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]